COMPLEXT PATIENT DERIVED ORGANOIDS(CPDOS) MODELING FOR ANTI-CANCER DRUG SCREENING

被引：0
|
作者：
Li, Ling
Knutsdottir, Hildur
Hui, Ken
Weiss, Matthew J.
He, Jin
Philosophe, Benjamin
Cameron, Andrew
Wolfgang, Christopher L.
Pawlik, Timothy M.
Ghiaur, Gabriel
Ewald, Andrew
Mezey, Esteban
Bader, Joel
Selaru, Florin
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
490e
引用
收藏
页码：S1508 / S1508
页数：1
相关论文
共 50 条
  • [41] Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
    Kim, Minsuh
    Mun, Hyemin
    Sung, Chang Oak
    Cho, Eun Jeong
    Jeon, Hye-Joon
    Chun, Sung-Min
    Jung, Da Jung
    Shin, Tae Hoon
    Jeong, Gi Seok
    Kim, Dong Kwan
    Choi, Eun Kyung
    Jeong, Seong-Yun
    Taylor, Alison M.
    Jain, Sejal
    Meyerson, Matthew
    Jang, Se Jin
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [42] Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
    Minsuh Kim
    Hyemin Mun
    Chang Oak Sung
    Eun Jeong Cho
    Hye-Joon Jeon
    Sung-Min Chun
    Da Jung Jung
    Tae Hoon Shin
    Gi Seok Jeong
    Dong Kwan Kim
    Eun Kyung Choi
    Seong-Yun Jeong
    Alison M. Taylor
    Sejal Jain
    Matthew Meyerson
    Se Jin Jang
    Nature Communications, 10
  • [43] Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment
    A. H. M. de Vries Schultink
    A. A. Suleiman
    J. H. M. Schellens
    J. H. Beijnen
    A. D. R. Huitema
    European Journal of Clinical Pharmacology, 2016, 72 : 645 - 653
  • [44] Breast cancer organoids derived from patients: A platform for tailored drug screening
    Tzeng, Yen-Dun Tony
    Hsiao, Jui-Hu
    Tseng, Ling-Ming
    Hou, Ming-Feng
    Li, Chia-Jung
    BIOCHEMICAL PHARMACOLOGY, 2023, 217
  • [45] PKPD modeling of acquired resistance to anti-cancer drug treatment
    Miro J. Eigenmann
    Nicolas Frances
    Thierry Lavé
    Antje-Christine Walz
    Journal of Pharmacokinetics and Pharmacodynamics, 2017, 44 : 617 - 630
  • [46] Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment
    Schultink, A. H. M. de Vries
    Suleiman, A. A.
    Schellens, J. H. M.
    Beijnen, J. H.
    Huitema, A. D. R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (06) : 645 - 653
  • [47] PKPD modeling of acquired resistance to anti-cancer drug treatment
    Eigenmann, Miro J.
    Frances, Nicolas
    Lave, Thierry
    Walz, Antje-Christine
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 (06) : 617 - 630
  • [48] High-throughput screening of patient-derived HCC organoids for drug discovery
    Michelle, Alissa
    Wong, Go
    Cheung, Winnie
    Wong, Maggie
    Wong, Aikha
    Lam, Helena
    Zhang, Zhe
    Man, Matthew
    Chen, Hui
    Close, David
    Johnston, Paul
    Chan, Anthony
    Lai, Paul
    Kwong, Joseph
    Wong, Nathalie
    CANCER RESEARCH, 2020, 80 (16)
  • [49] Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing
    Psilopatis, Iason
    Sykaras, Alexandros G. G.
    Mandrakis, Georgios
    Vrettou, Kleio
    Theocharis, Stamatios
    BIOMEDICINES, 2023, 11 (01)
  • [50] Patient-Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
    Li, Zhichao
    Xu, Haibo
    Gong, Yanqing
    Chen, Wei
    Zhan, Yonghao
    Yu, Lei
    Sun, Yangyang
    Li, Aolin
    He, Shiming
    Guan, Bao
    Wu, Yucai
    Xiong, Gengyan
    Fang, Dong
    He, Yuhui
    Tang, Qi
    Yao, Lin
    Hu, Zheng
    Mei, Hongbing
    He, Zhisong
    Cai, Zhiming
    Guo, Yinglu
    Li, Xuesong
    Zhou, Liqun
    Huang, Weiren
    ADVANCED SCIENCE, 2022, 9 (04)
12345